4//SEC Filing
ALEXION PHARMACEUTICALS INC 4
Accession 0000899866-16-000373
CIK 0000899866operating
Filed
Nov 6, 7:00 PM ET
Accepted
Nov 7, 7:44 PM ET
Size
22.4 KB
Accession
0000899866-16-000373
Insider Transaction Report
Form 4
BELL LEONARD
DirectorCEO
Transactions
- Sale
Common Stock, par value $.0001 per share
2016-11-04$139.90/sh−334$46,727→ 404,621 total(indirect: By Trust) - Sale
Common Stock, par value $.0001 per share
2016-11-04$144.90/sh−334$48,397→ 404,287 total(indirect: By Trust) - Exercise/Conversion
Common Stock, par value $.0001 per share
2016-11-04$22.90/sh+36,649$839,262→ 440,936 total - Sale
Common Stock, par value $.0001 per share
2016-11-04$136.00/sh−100$13,600→ 440,836 total - Sale
Common Stock, par value $.0001 per share
2016-11-04$137.77/sh−2,600$358,202→ 438,236 total - Sale
Common Stock, par value $.0001 per share
2016-11-04$139.05/sh−9,020$1,254,231→ 429,216 total - Sale
Common Stock, par value $.0001 per share
2016-11-04$139.98/sh−11,838$1,657,083→ 417,378 total - Sale
Common Stock, par value $.0001 per share
2016-11-04$140.83/sh−8,521$1,200,012→ 408,857 total - Sale
Common Stock, par value $.0001 per share
2016-11-04$141.84/sh−831$117,869→ 408,026 total - Sale
Common Stock, par value $.0001 per share
2016-11-04$145.06/sh−3,739$542,379→ 404,287 total - Exercise/Conversion
Option to Purchase Common Stock
2016-11-04−36,649→ 116,001 totalExercise: $22.90From: 2010-04-28Exp: 2020-01-28→ Common Stock, par value $.0001 per share (36,649 underlying)
Footnotes (7)
- [F1]The transaction is made pursuant to the terms of a sales plan designed to meet the requirements of Rule 10b5-1(c)(1) of the Securities Exchange Act.
- [F2]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $137.27 - $138.27. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
- [F3]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $138.38 - $139.38. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
- [F4]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $139.44 - $140.44. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
- [F5]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $140.44 - $141.44. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
- [F6]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $141.66 - $142.66. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
- [F7]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $144.90 - $145.90. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
Documents
Issuer
ALEXION PHARMACEUTICALS INC
CIK 0000899866
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000899866
Filing Metadata
- Form type
- 4
- Filed
- Nov 6, 7:00 PM ET
- Accepted
- Nov 7, 7:44 PM ET
- Size
- 22.4 KB